MOCKA, SARA
 Distribuzione geografica
Continente #
NA - Nord America 80
EU - Europa 18
AS - Asia 11
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 1
Totale 118
Nazione #
US - Stati Uniti d'America 78
IT - Italia 8
SE - Svezia 6
SG - Singapore 4
PK - Pakistan 3
CA - Canada 2
CN - Cina 2
DE - Germania 2
ES - Italia 1
GE - Georgia 1
HK - Hong Kong 1
NL - Olanda 1
UY - Uruguay 1
Totale 110
Città #
New York 17
Council Bluffs 8
San Jose 8
Dallas 7
Orangeburg 6
Catania 4
Newark 4
Agawam 3
Medford 3
Beijing 2
Biancavilla 2
Faisalabad 2
Phoenix 2
Singapore 2
Ankeny 1
Ashburn 1
Barcelona 1
Birmingham 1
Camden 1
Chicago 1
Detroit 1
Edmonton 1
Fair Lawn 1
Groves 1
Hong Kong 1
Huntington 1
Lahore 1
Los Angeles 1
Montevideo 1
Naples 1
Orlando 1
Providence 1
Salt Lake City 1
Santa Clara 1
The Bronx 1
Toronto 1
Williamsburg 1
Totale 93
Nome #
Design development and in vitro evaluation of mutual prodrugs combining 5-fluorouracil and HO-1 inhibitor with antiproliferative effect. 18
3-Heteroarylcoumarins as Potential Therapeutic Agents for Neurodegenerative Diseases: Synthesis, Molecular Modeling and Biological Insights. 18
Exploring the Potential of 3-Heteroaryl-6/7-Hydroxycoumarins against Neurodegenerative Diseases: Synthesis, Characterization, Molecular Modelling and Preliminary Biological Results 16
Development of dual A1/A2A adenosine receptor antagonists as nondopaminergic therapeutic agents for Parkinson’s disease 16
New mutual prodrugs of 5-fluorouracil and heme oxygenase 1 inhibitor with antiproliferative effects on breast cancer cells 15
Design and synthesis of imidazole and triazole derivatives as new heme oxygenase 1 inhibitors 14
Development of 5-fluorouracil and heme oxygenase 1 inhibitor mutual prodrugs as an innovative anticancer strategy 14
Synthesis of new 5-fluorouracil and heme oxygenase 1 inhibitor mutual prodrugs with antiproliferative effects. 7
Totale 118
Categoria #
all - tutte 701
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 701


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/202610 0 0 0 0 0 0 0 0 0 0 0 10
2026/2027108 24 62 22 0 0 0 0 0 0 0 0 0
Totale 118